Articles producció científica> Medicina i Cirurgia

The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases

  • Datos identificativos

    Identificador: PC:2622
    Autores:
    Rodríguez-Calvo, R.Tajes, M.Vázquez-Carrera, M.
    Resumen:
    DOI: 10.1080/14728222.2017.1279146 URL: http://www.tandfonline.com/doi/full/10.1080/14728222.2017.1279146 Filiació URV: SI Memòria
  • Otros:

    Autor según el artículo: Rodríguez-Calvo, R.; Tajes, M.; Vázquez-Carrera, M.
    Departamento: Medicina i Cirurgia
    Autor/es de la URV: RODRIGUEZ CALVO, RICARDO
    Palabras clave: Chemokines Cytokines inflammation
    Resumen: Introduction: Prolonged inflammatory response contributes to the pathogenesis of chronic disease-related disturbances. Among nuclear receptors (NRs), the orphan NR4A subfamily, which includes Nur77 (NR4A1), Nurr1 (NR4A2) and NOR1 (NR4A3), has recently emerged as a therapeutic target for the treatment of inflammation. Areas covered: This review focuses on the capacity of NR4A receptors to counter-regulate the development of the inflammatory response, with a special focus on the molecular transrepression mechanisms. Expert opinion: Recent studies have highlighted the role of NR4A receptors as significant regulators of the inflammatory response. NR4A receptors are rapidly induced by inflammatory stimuli, thus suggesting that they are required for the initiation of inflammation. Nevertheless, NR4A anti-inflammatory properties indicate that this acute regulation could be a protective reaction aimed at resolving inflammation in the later stages. Therefore, NR4A receptors are involved in a negative feedback mechanism to maintain the inflammatory balance. However, the underlying mechanisms are not entirely clear. Only a small number of NR4A-target genes have been identified, and the transcriptional repression mechanisms are only beginning to emerge. Despite further research is needed to fully understand the role of NR4A receptors in inflammation, these NRs should be considered as targets for new therapeutic approaches to inflammatory diseases.
    Grupo de investigación: Unitat de Recerca de Lípids i Arteriosclerosi
    Áreas temáticas: Ciències de la salut Ciencias de la salud Health sciences
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 1472-8222
    Fecha de alta del registro: 2017-03-06
    Página final: 304
    Volumen de revista: 21
    Versión del articulo depositado: info:eu-repo/semantics/acceptedVersion
    Enlace a la fuente original: https://www.tandfonline.com/doi/abs/10.1080/14728222.2017.1279146?journalCode=iett20
    URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
    DOI del artículo: 10.1080/14728222.2017.1279146
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2017
    Página inicial: 291
    Tipo de publicación: Article Artículo Article
  • Palabras clave:

    Inflamació
    Citoquines
    Quimiocines
    Chemokines
    Cytokines
    inflammation
    Ciències de la salut
    Ciencias de la salud
    Health sciences
    1472-8222
  • Documentos:

  • Cerca a google

    Search to google scholar